Star Combo Pharma Ltd - Asset Resilience Ratio

Latest as of June 2025: 67.35%

Star Combo Pharma Ltd (S66) has an Asset Resilience Ratio of 67.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read S66 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

AU$32.63 Million
≈ $23.09 Million USD Cash + Short-term Investments

Total Assets

AU$48.45 Million
≈ $34.28 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Star Combo Pharma Ltd's Asset Resilience Ratio has changed over time. See S66 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Star Combo Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see S66 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$18.11 Million 37.38%
Short-term Investments AU$14.52 Million 29.97%
Total Liquid Assets AU$32.63 Million 67.35%

Asset Resilience Insights

  • Very High Liquidity: Star Combo Pharma Ltd maintains exceptional liquid asset reserves at 67.35% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Star Combo Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Star Combo Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Chongqing Baiya Sanitary Products Co
SHE:003006
Household & Personal Products 9.52%
Fujian Green Pine Co Ltd
SHE:300132
Household & Personal Products 2.72%
Chungdamglobal Co. Ltd.
KQ:362320
Household & Personal Products 16.00%
Rigolleau SA
BA:RIGO
Household & Personal Products 0.27%
Anagenics Ltd
AU:AN1
Household & Personal Products 7.19%
ZOONO Group Ltd
AU:ZNO
Household & Personal Products 0.87%
Mcphersons Ltd
AU:MCP
Household & Personal Products 8.08%
Skin Elements Ltd
AU:SKN
Household & Personal Products 21.26%

Annual Asset Resilience Ratio for Star Combo Pharma Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Star Combo Pharma Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 29.97% AU$14.52 Million
≈ $10.27 Million
AU$48.45 Million
≈ $34.28 Million
+17.84pp
2024-06-30 12.13% AU$5.20 Million
≈ $3.68 Million
AU$42.82 Million
≈ $30.29 Million
-18.65pp
2023-06-30 30.79% AU$13.00 Million
≈ $9.20 Million
AU$42.23 Million
≈ $29.88 Million
+3.16pp
2022-06-30 27.62% AU$12.00 Million
≈ $8.49 Million
AU$43.44 Million
≈ $30.74 Million
-23.44pp
2021-06-30 51.06% AU$22.12 Million
≈ $15.65 Million
AU$43.32 Million
≈ $30.65 Million
+14.51pp
2020-06-30 36.55% AU$20.00 Million
≈ $14.15 Million
AU$54.72 Million
≈ $38.72 Million
+32.91pp
2019-06-30 3.64% AU$1.00 Million
≈ $709.00K
AU$27.51 Million
≈ $19.46 Million
--
pp = percentage points

About Star Combo Pharma Ltd

AU:S66 Australia Household & Personal Products
Market Cap
$18.64 Million
AU$26.34 Million AUD
Market Cap Rank
#25234 Global
#1116 in Australia
Share Price
AU$0.20
Change (1 day)
-13.33%
52-Week Range
AU$0.14 - AU$0.27
All Time High
AU$1.72
About

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more